University Of California Los Angeles

Tofacitinib is associated with a numerically higher incidence of major adverse cardiac events, versus TNF inhibitors, in patients with rheumatoid arthritis at an increased cardiac risk, according to data presented at ACR Convergence 2021.

The FDA has granted investigational device exemption approval to Rapid Medical for a trial to expand stroke treatment to distal brain regions, according to a press release.

Race and residence are both independently associated with lupus nephritis mortality, with Black patients and those living in large central metropolitan areas demonstrating the highest rates, according to data presented at ACR Convergence 2021.

A collaborative team of cancer experts from leading academic institutions and organizations has released recommendations for optimal protection against COVID-19 among individuals with blood cancer.

Although various studies have established the prognostic value of coronary artery calcium scoring for predicting atherosclerotic risk, some current models do not take coronary calcium into account, a speaker reported.

Levetiracetam was well tolerated and appeared to improve performance on spatial memory and executive function tasks among patients with Alzheimer’s disease, according to results of a randomized clinical trial in JAMA Neurology.

Patients with neurological conditions had an increased risk for adverse childhood experiences compared with the overall U.S. population, according to results of a cross-sectional study published in Neurology: Clinical Practice.

Cristina Puig-Saus, PhD, and Daniel S. Shin, MD, PhD, of UCLA Jonsson Comprehensive Cancer Center received a $1 million award from the U.S. Department of Defense for research into novel cell therapies for rare melanomas.

Nonpharmacological sleep interventions were effective in reducing anxiety and sleep-related thought processes, and these benefits were more substantial in patients with anxiety, according to a recent meta-analysis.

A routine ultrasound during the third trimester of pregnancy did not significantly affect pregnancy-related anxiety or mother-to-infant bonding, according to results of a pragmatic cluster-randomized controlled trial conducted in the Netherlands.